Mr. Speaker, my question is for the Minister of Health.
Several drugs used in the treatment of HIV and AIDS have been available in the United States, Europe and South America for more than a year already. But the Health Protection Branch has yet to authorize the marketing of these new drugs, thereby penalizing thousands of infected individuals.
Does the minister realize that, due to the particular inefficiency of the drug licensing process in Canada, thousands of people living with HIV or AIDS are seeing their treatment threatened?